. 2017 Oct 4;17:673. doi: 10.1186/s12885-017-3650-5

Table 2.

Correlation between the clinicopathological features and expression of miR-216

Patient characteristics		miR-216 expression		P-value
Patient characteristics		Low	High	P-value
Age (years)	≤55	36	40	0.627
Age (years)	>55	39	35	0.627
FIGO stage	I, II	10	41	< 0.001
FIGO stage	III, IV	65	34	< 0.001
Histology	Squamous	54	67	= 0.012
Histology	Others	21	8	= 0.012
Survival status	Alive	9	46	< 0.001
Survival status	Dead	66	29	< 0.001

Patient number of miR-216b-low and miR-216b-high groups and the corresponding proportion (%) were shown. The clinicopathological differences between miR-216b-low and miR-216b- high groups were analyzed using Pearson’s χ2 test